Meadow Creek Investment Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Meadow Creek Investment Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,670	Closed	-$575K	–	1356
2017 Q4	$575K	Buy	10,670 +2,288	+27%	+$125K	0.01%	613
2017 Q3	$478K	Sell	8,382 -2,530	-23%	-$148K	0.01%	620
2017 Q2	$657K	Buy	10,912 +6,820	+167%	+$388K	0.02%	521
2017 Q1	$223K	Buy	+4,092	New	+$202K	0.01%	713

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Meadow Creek Investment Management's BIVV Position: Q1 2018 in Review

Meadow Creek Investment Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 10,670 shares — an estimated $575K sold.

Meadow Creek Investment Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $657K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Meadow Creek Investment Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Meadow Creek Investment Management sold 10,670 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $575K.
Meadow Creek Investment Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Meadow Creek Investment Management's Bioverativ Inc. Common Stock position peaked at $657K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Meadow Creek Investment Management's 13F filing for Q1 2018, filed 9 May 2018.